CD4 and myeloid sarcoma: Previous studies have shown that MS is characterized by immune dysregulation, mainly driven by myelin-specific autoreactive CD4+T cells, and is closely related to immune dysfunction, transitional activation of immune cells, and an imbalance in the ratio of immune cell subpopulations [5–7].